Basics AbCellera Biologics Inc. IPO Date: December 11, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.28B Activated in VL: True Average Daily Range Avg Daily Range: $0.36 | 3.09% Avg Daily Range (30 D): $0.10 | 2.57% Avg Daily Range (90 D): $0.14 | 3.17% Institutional Daily Volume Avg Daily Volume: 2.37M Avg Daily Volume (30 D): 3.56M Avg Daily Volume (90 D): 4.5M Trade Size Avg Trade Size (Sh.): 165 Avg Trade Size (Sh.) (30 D): 229 Avg Trade Size (Sh.) (90 D): 219 Institutional Trades Total Inst.Trades: 1,297 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $.81M Avg Inst. Trade (90 D): $.94M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.95M Avg Closing Trade (30 D): $.71M Avg Closing Trade (90 D): $.77M Avg Closing Volume: 199.45K     News Aug 14, 2025 @ 11:23 AM Prelude Cuts Q2 Losses and Costs 13% Source: Jesterai Jul 30, 2025 @ 5:00 PM Global Antibody Discovery Market to Observe Stupen... Source: Delveinsight Jun 13, 2024 @ 9:40 AM Down 57%, Is AbCellera Biologics a Buy on the Dip?... Source: newsfeedback@fool.com (Cory Renauer) May 8, 2024 @ 8:30 AM AbCellera Biologics (ABCL) Q1 2024 Earnings Call T... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 7, 2024 @ 10:05 PM AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M... Source: Zacks Equity Research Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.19 $-.12 Diluted EPS $-.19 $-.12 Revenue $ $ 8.96M $ 17.08M Gross Profit $ $ $ Net Income / Loss $ $ -57.12M $ -34.73M Operating Income / Loss $ $ -76.28M $ -49.59M Cost of Revenue $ $ $ Net Cash Flow $ $ -9.28M $ -66.83M PE Ratio